Amalgamated Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Amalgamated Financial’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$607K	Buy	+16,909	New	+$479K	﹤0.01%	1435

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Amalgamated Financial's AMPH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2022: 16,909 shares worth $607K. The stake represents ﹤0.01% of the portfolio and ranks #1435 among its holdings.

203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

Amalgamated Financial held 16,909 shares of Amphastar Pharmaceuticals worth $607K as of Q1 2022.
Amphastar Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
Amphastar Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1435 holding.
203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.